These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31211843)

  • 1. AAV9-mediated delivery of miR-23a reduces disease severity in Smn2B/-SMA model mice.
    Kaifer KA; Villalón E; O'Brien BS; Sison SL; Smith CE; Simon ME; Marquez J; O'Day S; Hopkins AE; Neff R; Rindt H; Ebert AD; Lorson CL
    Hum Mol Genet; 2019 Oct; 28(19):3199-3210. PubMed ID: 31211843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astrocyte-produced miR-146a as a mediator of motor neuron loss in spinal muscular atrophy.
    Sison SL; Patitucci TN; Seminary ER; Villalon E; Lorson CL; Ebert AD
    Hum Mol Genet; 2017 Sep; 26(17):3409-3420. PubMed ID: 28637335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN depletion decreases disease severity and modestly prolongs survival in a mouse model of spinal muscular atrophy.
    Little D; Valori CF; Mutsaers CA; Bennett EJ; Wyles M; Sharrack B; Shaw PJ; Gillingwater TH; Azzouz M; Ning K
    Mol Ther; 2015 Feb; 23(2):270-7. PubMed ID: 25369768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice.
    Dominguez E; Marais T; Chatauret N; Benkhelifa-Ziyyat S; Duque S; Ravassard P; Carcenac R; Astord S; Pereira de Moura A; Voit T; Barkats M
    Hum Mol Genet; 2011 Feb; 20(4):681-93. PubMed ID: 21118896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translational fidelity of intrathecal delivery of self-complementary AAV9-survival motor neuron 1 for spinal muscular atrophy.
    Passini MA; Bu J; Richards AM; Treleaven CM; Sullivan JA; O'Riordan CR; Scaria A; Kells AP; Samaranch L; San Sebastian W; Federici T; Fiandaca MS; Boulis NM; Bankiewicz KS; Shihabuddin LS; Cheng SH
    Hum Gene Ther; 2014 Jul; 25(7):619-30. PubMed ID: 24617515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal Gene Therapy Using a Single Injection of Recombinant AAV9 Rescued SMA Phenotype in Mice.
    Rashnonejad A; Amini Chermahini G; Gündüz C; Onay H; Aykut A; Durmaz B; Baka M; Su Q; Gao G; Özkınay F
    Mol Ther; 2019 Dec; 27(12):2123-2133. PubMed ID: 31543414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AAV9-Mediated Expression of SMN Restricted to Neurons Does Not Rescue the Spinal Muscular Atrophy Phenotype in Mice.
    Besse A; Astord S; Marais T; Roda M; Giroux B; Lejeune FX; Relaix F; Smeriglio P; Barkats M; Biferi MG
    Mol Ther; 2020 Aug; 28(8):1887-1901. PubMed ID: 32470325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.
    Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H
    Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AAV9-DOK7 gene therapy reduces disease severity in Smn
    Kaifer KA; Villalón E; Smith CE; Simon ME; Marquez J; Hopkins AE; Morcos TI; Lorson CL
    Biochem Biophys Res Commun; 2020 Sep; 530(1):107-114. PubMed ID: 32828271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AAV9-Stathmin1 gene delivery improves disease phenotype in an intermediate mouse model of spinal muscular atrophy.
    Villalón E; Kline RA; Smith CE; Lorson ZC; Osman EY; O'Day S; Murray LM; Lorson CL
    Hum Mol Genet; 2019 Nov; 28(22):3742-3754. PubMed ID: 31363739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA: a dose-response study in mice and nonhuman primates.
    Meyer K; Ferraiuolo L; Schmelzer L; Braun L; McGovern V; Likhite S; Michels O; Govoni A; Fitzgerald J; Morales P; Foust KD; Mendell JR; Burghes AH; Kaspar BK
    Mol Ther; 2015 Mar; 23(3):477-87. PubMed ID: 25358252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNA in spinal muscular atrophy pathogenesis and therapy.
    Magri F; Vanoli F; Corti S
    J Cell Mol Med; 2018 Feb; 22(2):755-767. PubMed ID: 29160009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocytes influence the severity of spinal muscular atrophy.
    Rindt H; Feng Z; Mazzasette C; Glascock JJ; Valdivia D; Pyles N; Crawford TO; Swoboda KJ; Patitucci TN; Ebert AD; Sumner CJ; Ko CP; Lorson CL
    Hum Mol Genet; 2015 Jul; 24(14):4094-102. PubMed ID: 25911676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMA Human iPSC-Derived Motor Neurons Show Perturbed Differentiation and Reduced miR-335-5p Expression.
    Murdocca M; Ciafrè SA; Spitalieri P; Talarico RV; Sanchez M; Novelli G; Sangiuolo F
    Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27483257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AAV9-mediated SMN gene therapy rescues cardiac desmin but not lamin A/C and elastin dysregulation in Smn2B/- spinal muscular atrophy mice.
    Brown SJ; Šoltić D; Synowsky SA; Shirran SL; Chilcott E; Shorrock HK; Gillingwater TH; Yáñez-Muñoz RJ; Schneider B; Bowerman M; Fuller HR
    Hum Mol Genet; 2023 Oct; 32(20):2950-2965. PubMed ID: 37498175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seamless Genetic Conversion of SMN2 to SMN1 via CRISPR/Cpf1 and Single-Stranded Oligodeoxynucleotides in Spinal Muscular Atrophy Patient-Specific Induced Pluripotent Stem Cells.
    Zhou M; Hu Z; Qiu L; Zhou T; Feng M; Hu Q; Zeng B; Li Z; Sun Q; Wu Y; Liu X; Wu L; Liang D
    Hum Gene Ther; 2018 Nov; 29(11):1252-1263. PubMed ID: 29598153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramuscular scAAV9-SMN injection mediates widespread gene delivery to the spinal cord and decreases disease severity in SMA mice.
    Benkhelifa-Ziyyat S; Besse A; Roda M; Duque S; Astord S; Carcenac R; Marais T; Barkats M
    Mol Ther; 2013 Feb; 21(2):282-90. PubMed ID: 23295949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal motor neuron loss occurs through a p53-and-p21-independent mechanism in the Smn
    Reedich EJ; Kalski M; Armijo N; Cox GA; DiDonato CJ
    Exp Neurol; 2021 Mar; 337():113587. PubMed ID: 33382987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Smn-independent beneficial effects of trichostatin A on an intermediate mouse model of spinal muscular atrophy.
    Liu H; Yazdani A; Murray LM; Beauvais A; Kothary R
    PLoS One; 2014; 9(7):e101225. PubMed ID: 24984019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the therapeutic window in a severe animal model of spinal muscular atrophy.
    Robbins KL; Glascock JJ; Osman EY; Miller MR; Lorson CL
    Hum Mol Genet; 2014 Sep; 23(17):4559-68. PubMed ID: 24722206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.